Outcomes in recent-onset inflammatory polyarthritis differ according to initial titers, persistence over time, and specificity of the autoantibodies.

Arthritis care & research

Volumn 62, Issue 11, 2010, Pages 1624-1632

  Guzian, Marie Caroline ^a   Carrier, Nathalie ^b   Cossette, Pierre ^b   de Brum Fernandes, Artur J ^b   Liang, Patrick ^b   Ménard, Henri A ^b   Boire, Gilles ^b  

^a CENTRE HOSPITALIER UNIVERSITAIRE DE SHERBROOKE   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; IMMUNOGLOBULIN M; RHEUMATOID FACTOR;

ADULT; AGED; ANTIBODY SPECIFICITY; ARTHRITIS; ARTICLE; BIOSYNTHESIS; BLOOD; CLINICAL TRIAL; COHORT ANALYSIS; COMPARATIVE STUDY; FEMALE; FOLLOW UP; HUMAN; IMMUNOLOGY; INFLAMMATION; LONGITUDINAL STUDY; MALE; MIDDLE AGED; PHYSIOLOGY; PROSPECTIVE STUDY; TIME; TREATMENT OUTCOME;

ADULT; AGED; ANTIBODY SPECIFICITY; ARTHRITIS; AUTOANTIBODIES; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOGLOBULIN M; INFLAMMATION; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RHEUMATOID FACTOR; TIME FACTORS; TREATMENT OUTCOME;

MLCS; MLOWN;

EID: 79952055560     PISSN: None     EISSN: 21514658     Source Type: Journal    
DOI: 10.1002/acr.20288     Document Type: Article

References (0)